Yungjin Pharm. Co., Ltd. (003520.KS) KSC

Currency In KRW

AD

Valuation

Market Cap389.03B
Enterprise Value454.6B
P/E Ratio-18.86
PEG Ratio0.03
Price/Sales Ratio0.58
Price/Book Ratio1.72
Enterprise/Revenue0.87
Enterprise/EBITDA942.06

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.03
Operating Margin-0.03
AD

Management Effectiveness

Return On Assets-0.03
Return On Equity-0.09

Income Statement

Revenue254.26B
Revenue/Share1,393.52
Gross Profit75.86B
EBITDA12.2B
Net Income-227.66M
Diluted EPS-1.24

Balance Sheet

Total Cash3.59B
Total Cash/Share19.61
Total Debt77.24B
Total Debt/Equity0.9
Current Ratio1.47
Book Value Per Share471.08

Price History

52-Week Change-58.69
52-Week High2,320
52-Week Low798
Moving Average 50 Days1,010.98
Moving Average 200 Days1,410.74

Statistics

Average Volume358,588
Shares Outstanding182.89M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor563:500
Last Split DateJune 18, 2010
AD